Resources describe NSF risks from gadolinium MR contrast media use

February 26, 2008 Resources describe NSF risks from gadolinium MR contrast media use James Brice -------------------------------------------------------------------------------- Several new resources offer radiologists, nephrologists, and other clinicians answers to many questions associated with nephrogenic systemic fibrosis and gadolinium-based MRI contrast. Directed by nephrologist Dr. Richard Swartz, University of Michigan researchers have confirmed a strong association between NSF and gadolinium-based contrast. An evaluation of medical records in the university hospital's dermatopathology database identified 29 NSF cases diagnosed between November 1999 and December 2006. All 29 had compromised renal function, and 25 were known to have received a gadolinium-based contrast medium.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC